# Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)

> **NCT04025424** · — · UNKNOWN · sponsor: **Russian Academy of Medical Sciences** · enrollment: 350 (estimated)

## Conditions studied

- Melanoma
- Squamous Cell Lung Cancer
- Uveal Melanoma
- Hodgkin Lymphoma

## Interventions

- **GENETIC:** Genetic tests of the available tumor and plasma samples

## Key facts

- **NCT ID:** NCT04025424
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-15
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-12-01
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04025424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04025424, "Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04025424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*